This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Oil Companies on Slippery Ground as Harvey Hampers Production
by Zacks Equity Research
The Harvey impact is evident on oil companies as some of them have already revised their guidance.
Core Laboratories (CLB) Down 17.7% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Strong Sell Stocks the Market Gave Up On
by David Bartosiak
With stocks coming under pressure, these five names are at lows and heading lower
Core Laboratories (CLB) Q2 Earnings Top Estimates, Sales Lag
by Zacks Equity Research
Core Laboratories N.V. (CLB) surpassed earnings estimates in the second quarter due to higher operating income and revenues in the product enhancement segment.
Peek Into Oil Q2 Earnings on Jul 24: HAL, APC & CLB
by Nilanjan Choudhury
Of the 16 Zacks sectors, energy is expected to report the highest year-over-year earnings growth in Q2.
Are U.S. Shale Players Winning the Oil War Against OPEC?
by Zacks Equity Research
Shale players enjoy an edge over the OPEC in the production ramp up race, courtesy of the signing of a historical output cut deal by the cartel.
Why Is Core Laboratories (CLB) Down 6.8% Since the Last Earnings Report?
by Zacks Equity Research
Core Laboratories N.V. (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Tops Earnings and Revenues in Q1
by Zacks Equity Research
Core Laboratories N.V. (CLB) reported first-quarter 2017 adjusted diluted earnings of 42 cents per share, surpassing the Zacks Consensus Estimate of 39 cents.
Core Laboratories (CLB) Q1 Earnings: Will it Disappoint?
by Zacks Equity Research
Core Laboratories N.V. (CLB) is set to report first-quarter 2017 results after the closing bell on Apr 19.
Why Is Core Laboratories (CLB) Down 4.9% Since the Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q4 Earnings in Line, Revenues Top
by Zacks Equity Research
Oilfield services company Core Laboratories N.V.'s (CLB) fourth-quarter 2016 adjusted diluted earnings of 41 cents per share came in line with the Zacks Consensus Estimate.
Why Earnings Season Could Be Great for Core Laboratories (CLB)
by Zacks Equity Research
Investors are always looking for stocks that are poised to beat at earnings season and Core Laboratories N.V. (CLB) may be one such company.
Oil Stock Q4 Earnings to Watch on Jan 25: CLB, RES, FTK
by Nilanjan Choudhury
Let's see what's in store for three oilfield services providers CLB, RES and FTK that are reporting tomorrow.
What's in Store for Baker Hughes (BHI) in Q4 Earnings?
by Zacks Equity Research
Baker Hughes Incorporated (BHI) is set to report fourth-quarter 2016 results on Jan 26, before the opening bell.
Core Laboratories (CLB) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Oilfield services company Core Laboratories N.V. (CLB) is set to release fourth-quarter 2016 results after the closing bell on Jan 25.
New Strong Buy Stocks for July 25th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Bear of the Day: Core Labs (CLB)
by Jeremy Mullin
Exposure to lower oil prices continues to keep investors away from this stock.
4 Surging Oil Stocks Squeezing Higher
by Jeremy Mullin
The recent rise in crude oil has oil stocks headed higher. Now is an opportunity to sell.